COMP <GO>
CORZ vs ENVA // 10Y YIELD & FRED MACRO BETA
Core Scientific Inc. (NASDAQ) VS. Enova International Inc. (NYSE) • 15-METRIC TALLY: CORZ 0
— ENVA 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: ENVA
LAST: $13.25 (-8.18%) • MKT CAP: $4.26B
macro-sensitivity
1.12
LAST: $174.09 (-3.84%) • MKT CAP: $4.26B
macro-sensitivity
1.16
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CORZ VS. ENVA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CORZ | ENVA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 17.10% | -52.10 | ENVA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 7.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.72% | 22.00% | -31.72 | ENVA | /fcf-yield <GO> |
| Operating Margin | -60.00% | 23.50% | -83.50 | ENVA | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 9.80% | -69.80 | ENVA | /net-margins <GO> |
| Revenue Growth (YoY) | -37.50% | 18.60% | -56.10 | ENVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | ENVA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.8 | 44.5 | -3.70 | ENVA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.12 | 1.16 | -0.04 | ENVA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 12.1x | +16.90 | ENVA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.26B | $4.26B | -$494.1K | ENVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CORZ REV | ENVA REV | CORZ GROSS % | ENVA GROSS % | CORZ FCF | ENVA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $319.0M | $3.15B | 11.9% | 58.1% | -$450.8M | $1.68B |
| FY 2024 | $510.7M | $2.66B | 23.7% | 57.5% | -$52.1M | $1.42B |
| FY 2023 | $502.4M | $2.12B | — | — | $42.5M | $1.07B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CORZ // BETA 1.12
ENVA // BETA 1.16